Wednesday, February 10, 2010, 3:04am EST - Canadian Markets open in 6 hours and 26 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Cambrex Corp. (CBM)

 On Feb 9: 5.27 USD   0.00 (0.00%)  
MORE ON CBM
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
CAMBREX CP (NYSE:CBM) Delayed quote dataEdit
Last Trade: 5.27 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 5.27
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 12.00
Day's Range: N/A - N/A
52wk Range: 1.48 - 7.22
Volume: 0
Avg Vol (3m): 102,471
Market Cap: 154.33M
P/E (ttm): 0.81
EPS (ttm): 6.51
Div & Yield: N/A (N/A%)
Cambrex Corp. (CBM)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add CBM to Portfolio   Download Data

HEADLINES
• CAMBREX CORP Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Fri, Feb 5)
• Cambrex To Announce Fourth Quarter 2009 Financial Results On February 10, 2010
PRNewswire (Thu, Feb 4)
• Cambrex Presentation at the JPMorgan Healthcare Conference to be Webcast
PRNewswire (Tue, Jan 5)
• CAMBREX CORP Financials
EDGAR Online Financials (Sat, Nov 7)
• CAMBREX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Wed, Nov 4)
• Cambrex Earnings Call scheduled for 8:30 am ET today
CCBN (Wed, Nov 4)
• CAMBREX CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Mon, Aug 24)
• CAMBREX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Wed, Aug 5)
• CAMBREX CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tran
EDGAR Online (Thu, Jun 4)
• CAMBREX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Wed, May 6)
More Headlines for CBM...
ANALYST
EPS Est (next year) (Dec-07) : N/A
EPS Est (in 2 years) (Dec-08) : N/A
Avg Rec (current)*: 2.3
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Cambrex Corporation provides various products and services that enable the development and commercialization of branded and generic small molecule therapeutics.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices